Navigation Links
MarketsandMarkets: Global Biochip (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Market to Reach $5.6 Billion by 2015

DALLAS, Texas, August 17, 2011 /PRNewswire/ --

The "Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)" analyzes the biochip market by types and applications and studies the major market drivers, restraints, opportunities, and market trends for biochip market in North America, Europe, Asia, and Rest of the World.

Browse market data tables and in-depth TOC on "Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)".
Early buyers will receive 10% customization on reports.

Biochips were developed and commercialized in the eighties. Since then, market has offered tremendous growth and hence seen an influx of players vying fiercely for a share of this market. The global biochips market is studied by the types and key applications. It was valued at $2.6 billion in 2010 and is expected to reach $5.6 Billion by 2015; growing at a CAGR of 16.7%.Major players in this market include Affymetrix, Inc. (U.S.), Illumnia, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Roche NimbleGen (U.S.), Sequenom Inc, (U.S.), Luminex Corporation (U.S.), Bio-Rad Laboratories (U.S.), Biacore Life Sciences by GE Healthcare (Sweden), EMD Millipore (U.S.), Life Technologies (U.S.), Perkin Elmer (U.S.), Caliper Life Sciences (U.S.), Fluidigm Corporation (U.S.), Cepheid (U.S.), Epoch Biosciences (U.S.), US Biomax (U.S.), Sigma Aldrich (U.S.), Biochain Institute, Inc. (U.S.), Origene (U.S.), Super BioChips (South Korea ), and IsuAbxis Co Ltd (Seoul, Korea).

"New product launches" and "agreements and collaborations" are the two main strategies adopted by the players to stay competitive in this market. The major applications in the market driving its growth in future include cancer diagnosis and treatment, expression profiling, and diagnostics since early detection of disease and targeted treatment options are still the unmet need of this market. There were 12.3 million new cases of cancer worldwide in 2007 and about 7.6 million deaths. These figures are estimated to rise up to 16 million new cancer diagnoses and about 10 million deaths by 2020 according to WHO & American Cancer Society.

Recently Published Reports by MarketsandMarkets

Upcoming Market Research by MarketsandMarkets

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website


Mr. Rohan
7557 Rambler Road,
Suite 727, Dallas, TX 75231
Tel: +1-888-6006-441
MarketsandMarkets Blog

SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MarketsandMarkets: Global Bioinformatics Market Worth $8.3 billion by 2014
2. MarketsandMarkets: Global Oncology Biomarkers Market Worth US$9.5 Billion by 2014
3. MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014
4. Marketsandmarkets: Global Minimally Invasive/ Non Invasive Market Worth $24.4 Billion by 2014
5. MarketsandMarkets: Global Biosimilars Product Market Worth $19.4 Billion by 2014
6. MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014
7. Global bioterrorism threat analyzed for world animal health office
8. Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule Revamilast
9. Global Microbiology Testing Market: Facilities, Test Volumes, and Sales Forecasts by Country
10. Scientists pinpoint river flow associated with cholera outbreaks, not just global warming
11. Lilly Global Giving Puts Power of Philanthropy in Employees Hands
Post Your Comments:
(Date:11/30/2015)... -- Champions Oncology, Inc. (CSBR), engaged in the development of ... and use of oncology drugs, today announced that ... at the LD MICRO Investor Conference on Wednesday, December ... conference, held at the Luxe Sunset Bel Air Hotel ... feature 200 small/micro-cap companies and is expected to host ...
(Date:11/30/2015)...  HUYA Bioscience International, the leader in accelerating global ... today announced it has signed a Memorandum of Understanding ... collaboration between KDDF and HUYA with the ultimate goal ... for the global market. China,s ... innovative preclinical and clinical stage compounds. The company advances ...
(Date:11/30/2015)... Germany , November 30, 2015 ... Vienna, Austria to be held December 1-4, ... in Vienna, Austria to be ... owned subsidiary of Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), announced ... Therapy Suite at the 3rd European Congress of NeuroRehabilitation ...
(Date:11/30/2015)... PETACH TIKVAH, Israel , Nov. 30, 2015 ... ), a leading developer of adult stem cell technologies for ... Therapeutics Ltd., has been awarded an additional grant of approximately ... Chief Scientist (OCS). This grant, the second this year, brings ... to approximately $1.8 million (approximately NIS7 million).  ...
Breaking Biology Technology:
(Date:10/29/2015)... Mich. , Oct. 29, 2015  Rubicon ... Genomics for U.S. distribution of its DNA library ... kit and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX ... enable the preparation of NGS libraries for liquid ... for diagnostic and prognostic applications in cancer and ...
(Date:10/27/2015)... -- In the present market scenario, security is one ... verticals such as banking, healthcare, defense, electronic gadgets, and ... secure & simplified access control and growing rate of ... bank accounts, misuse of users, , and so on. ... and smartphones are expected to provide potential opportunities for ...
(Date:10/26/2015)... and LAS VEGAS , ... Nok Labs , an innovator in modern authentication and ... today announced the launch of its latest version of ... platform enabling organizations to use standards-based authentication that supports ... Nok S3 Authentication Suite is ideal for organizations deploying ...
Breaking Biology News(10 mins):